Navigation Links
ALCiS(R) Daily Relief Now Available at Walgreens
Date:4/8/2008

Fast-acting topical pain reliever lands its first national retail drug

chain

SAN JOSE, Calif., April 8, 2008 /PRNewswire/ -- ALCiS Health, Inc., a provider of patented pain relief products, today announced that Walgreens, the nation's largest drugstore chain, is stocking its over-the-counter topical pain relief cream, ALCiS Daily Relief, at all of its 6,237 stores. Its introduction onto Walgreens' shelves across the United States marks the product's first national retail drug store account.

Brian Berchtold, president and CEO of ALCiS Health said, "I'm pleased with the reception ALCiS Daily Relief is getting by consumers and health care professionals alike."

Since its inception in 2004, ALCiS has focused on a sampling and educational program for health care professionals to help establish the ALCiS brand and demonstrate the product's efficacy to the medical community. Over 5,000 medical professionals, including pain specialists, rheumatologists, orthopedic surgeons and family practitioners, participate in the ALCiS sampling program.

"My patients who have used ALCiS Daily Relief have told me that they love this product," said Lonnie Zeltzer, MD, Director, Pediatric Pain Program, David Geffen School of Medicine at UCLA. "It's not messy, it's easy to use, and it relieves sore muscles."

ALCiS Daily Relief is a pleasantly scented, topical pain reliever that appeals to those consumers that retailers like Walgreens target everyday, particularly female baby boomers.

Including Walgreens, ALCiS Daily Relief can now be found on shelves at 8,200 retail stores including regional drugstore chains Duane Reade throughout the New York tri-state area, Longs Drugs in California and Nevada, and a host of other retail drugstore chains, as well as a select number of specialty sports retail stores.

About ALCiS Daily Relief

The innovative, advanced patented technology found in ALCiS Daily Relief pain cream provides relief from pain in as little as five minutes. The medicines are delivered without skin irritation -- no hot or cold sensation, just fast-acting pain relief. It can be used for the temporary relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, strains, sprains, and bruises, as well as back pain, neck pain, shoulder pain, foot pain, sore muscles, stiff joints and sports injuries. In addition, it can be used before and/or after any level of physical activity. For more information on where to find ALCiS Daily Relief, visit http://www.alcis.com/locator/

About ALCiS Health

ALCiS Health, Inc. (http://www.alcis.com), founded in 2004, and based in San Jose, California, markets innovative, patented pain relief products that address both the growing needs of athletic communities as well as the day-to-day needs of baby boomers. The company's products enable consumers to live more active and productive lives by providing temporary relief of aggravating aches and pains.


'/>"/>
SOURCE ALCiS Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
2. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
3. MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
4. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
5. Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting
6. Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis
7. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
8. BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana
9. Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
10. ValueRich Report on AMDL/China Available on Web Site
11. AMDL Presentation of China Success Story from Rodman & Renshaw Annual Healthcare Conference Available at WallStreetReporter.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... 21, 2017 , ... The University of Connecticut, in partnership ... three startups through the UConn Innovation Fund. The $1.5 million UConn Innovation Fund ... UConn. , The UConn Innovation Fund provides investments of up to $100,000 to ...
(Date:4/20/2017)... ... April 20, 2017 , ... As part of the ... challenging patient cases when screening for direct oral anticoagulant. When patients taking direct ... for bridging parental anticoagulation especially for those at high risk of thrombosis recurrence. ...
(Date:4/20/2017)... ... 20, 2017 , ... NetDimensions appoints Bill Mastin, a learning technology veteran, as ... experience in the learning technologies industry, Mastin joins NetDimensions from the New York office ... (LTG). At LEO, Mastin served as SVP of the North America offices and prior ...
(Date:4/20/2017)... 2017 Dutch philosopher Koert van Mensvoort - founder ... University of Technology in Eindhoven - has written a ,Letter to Humanity, ... on humanity to avoid becoming a slave and victim to its own technology, ... ... Dutch philosopher Koert van Mensvoort – founder of the Next Nature Network and ...
Breaking Biology Technology:
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... -- Trends, opportunities and forecast in this market to ... AFIS, iris recognition, facial recognition, hand geometry, vein recognition, ... industry (government and law enforcement, commercial and retail, health ... and by region ( North America , ... , and the Rest of the World) ...
Breaking Biology News(10 mins):